Adelaide
South Australia
Agilex Adelaide is the company’s headquarters and is the largest of our three facilities. It the FDA audited Centre of Excellence for Agilex’s bioanalytical services and is home to almost 200 Agilex staff spanning three divisions, LC/MS, Immunoassay and Immunobiology. These three departments make up Australia’s largest bioanalytical team. Our range of state-of-the-art instrumentation allows us to welcome any drug modality across a range of therapeutic indications.
- LC-MS
- ELISA
- MSD
- GYROLAB
- FLOW CYTOMETRY
- rtPCR ddPCR
- ELISPOT
- CELL CULTURE
- PBMC ISOLATION
Brisbane
Queensland
Agilex’s custom-built GLP toxicology lab in Brisbane, Queensland is home to Australia’s most experienced GLP toxicology team, specialising in rodent Pharmacokinetics (PK) and toxicology studies. In conjunction with our Global partners, we offer comprehensive IND-enabling packages that are expertly coordinated by Agilex’s Program Management team. With over 50 GLP packages completed in the last 5 years, this lab is Australia’s primary unit for toxicology.
Bioanalytical Brisbane
Queensland
Agilex’s newest facility, located on level 5 of the QIMR building in the heart of Brisbane city. Conveniently co-located with Australia’s largest Phase I trials site, Nucleus Network. Boasting a state-of-the-art flow cytometry lab and PBMC isolation room, this facility is perfectly positioned for speedy receipt of samples to allow for fast turnaround of data. Speak to our Principal Scientist about your assay needs and trust in our scientist to deliver high quality data.
International Agilex Partner –Primera (China and US)
We understand that following Phase I it’s common for sponsor to look at multi-site, multi-country options for their later phase trials. Let Agilex work with our international partner to transfer your methods around the world. Our harmonization on equipment, SOPs and close collaboration between our teams, means that the process is fast, low cost, and without quality compromise.
Primera is a global CRO with operations in US and China. We offer one-stop drug research and development services, including medicinal chemistry, DMPK, bioanalysis, data management and biostatistics, API & formulation process development, API commercial manufacturing, and pharmaceutical analysis. The services cover a wide range of drug modelity, such as chemical drugs, peptides and antibodies, ADC, oligonueclotide, CGT, and vaccines. Visit www.primera-corp.com, www.xihuasci.com, and www.tcmgroupsinc.com for more information.
